| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8448088 | European Journal of Cancer | 2010 | 7 Pages |
Abstract
A relative reduction in Pca metastasis of 53% and Pca mortality of 37% was observed in the intervention population after 8.5Â years of observation. The impact of overdiagnosis, quality of life benefits and cost-effectiveness need to be assessed before population-based PSA screening can be recommended.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Pim J. van Leeuwen, David Connolly, Anna Gavin, Monique J. Roobol, Amanda Black, Chris H. Bangma, Fritz H. Schröder,